CorMedix Therapeutics delivers eight commercial-stage products that address critical, unmet needs in vulnerable patient populations. Our portfolio spans both prevention and treatment, targeting serious, life-threatening infections across diverse care settings. Guided by our mission to protect patients and advance care, our team works tirelessly to expand access to our therapies and explore new opportunities to broaden our impact. Learn more at www.cormedix.com.